HSCD 621 Psychopharmacology I
This course provides a broad understanding of psychopharmacology related to substance use disorders. Following a review of pharmacokinetics, pharmacodynamics and synaptic and behavioral mechanisms of addictive drugs, the course focuses on medications used to treat substance use disorders. Students distinguish among the major classes of addictive drugs and medications used to treat substance use disorders, evaluate the evidence base for clinical effectiveness of such medications, and engage in clinical applications of this knowledge.
2 Graduate credits
Effective August 18, 2025 to present
Learning outcomes
General
- Demonstrate understanding of basic concepts in neuroanatomy and neurotransmission at a level appropriate for advanced non-scientist clinicians
- Distinguish among addictive drugs and medications used to treat substance use disorders regarding their pharmacological classifications, synaptic sites of action and effects on behavior
- Critique the evidence base for the utility of medications used to treat substance use disorders
- Educate clients and families about addictive drugs and medications used to treat substance use disorders as part of countering misinformation and shame and fostering common understanding
- Educate clients and families about addictive drugs and medications used to treat substance use disorders in a manner that supports informed client choice and adherence to treatment
- Educate policymakers about addictive drugs and medications used to treat substance use disorders in service of stigma reduction and advocacy
- Evaluate clients for referral to appropriate services, include detoxification services and care provision involving medications used to treat substance use disorders